Abstract
The use of lipids as taste-masking excipients in paracetamol sachets and chewable tablets without compromising drug release was investigated. Twelve paracetamol granule formulations were prepared by melt granulation, using Precirol® (glyceryl palmitostearate), cetyl alcohol and stearic acid, at different paracetamol-lipid ratios. Based on efficient taste-masking results coupled with minimum retardation of drug release, paracetamol-Precirol (1:1), paracetamol-cetyl alcohol (1:2) and paracetamol-stearic acid (1:2) granules were selected for preparation of chewable tablets and sachets. Formulations were evaluated for the effect of storage, at 40 °C and 75 % RH for 6 months, on their performance. Results inferred that paracetamol sachets, after reconstitution in 100 ml water, showed efficient taste-masking compared to control sachets (without lipids). The sachets released more than 90 % of their drug content in 30 min, when tested in 900 ml of phosphate buffered saline, pH 5.8. Chewable tablets exhibited comparable taste-masking effect to a reference product, Tylenol® 80 mg chewable tablets, and yielded similar drug dissolution profiles (similarity factor f 2 > 50). Differential scanning calorimetry indicated the absence of interaction between paracetamol and lipids. Scanning electron micrographs supported the obtained results. Upon storage at 40 °C and 75 % RH for 6 months, all the prepared sachets and chewable tablets were found to be stable except cetyl alcohol-based tablets that showed decrease in the efficiency of taste masking with increase in release rate. In conclusion, selected lipids, Precirol®, cetyl alcohol and stearic acid, could be efficiently used in formulation of taste masked paracetamol sachets and chewable tablets without adversely delaying drug release.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig6_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig7_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig8_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40005-014-0137-0/MediaObjects/40005_2014_137_Fig9_HTML.gif)
Similar content being viewed by others
References
Ahire S, Bankar V et al (2012) A review: taste masking techniques in pharmaceuticals. Pharm Sci Monitor 3(3):68–82
Albertini B, Cavallari C et al (2004) Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer. Eur J Pharm Sci 21(2):295–303
Arun P, Sandip C et al (2011) Evaluation of hot melt coating as taste masking tool. IRJP 2(8):169–172
Bladh N, Blychert E et al (2007) A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers. Clin Ther 29(4):640–649
Costa P, Sousa Lobo JM (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13(2):123–133
Cram A, Breitkreutz J et al (2009) Challenges of developing palatable oral paediatric formulations. Int J Pharm 365(1):1–3
El-Massik M (2006) Development of Cetirizine chewable tablets with inhibited bitterness using liquid solid compact technology. Alex J Pharm Sci 20(1):11–16
El-Massik M (2007) Preparation and evaluation of extended-release doxazosin lipid matrix granules. Alex J Pharm Sci 21(2):111–117
Gowan WG, Bruce RD (1993) Aliphatic esters as solventless coating pharmaceuticals. Can Pat Appl 11:CA2082137
Hejaz H, Karaman R et al (2012) Computer-assisted design for paracetamol masking bitter taste prodrugs. J Mol Model 18(1):103–114
Hulse WL, Grimsey IM et al (2008) The impact of low-level inorganic impurities on key physicochemical properties of paracetamol. Int J Pharm 349(1):61–65
Kamble R, Maheshwari M et al (2004) Melt solidification technique: incorporation of higher wax content in ibuprofen beads. AAPS PharmSciTech 5(4):75–83
Kaushik D, Dureja H (2014) Recent patents and patented technology platforms for pharmaceutical taste masking. Recent Pat Drug Deliv Formul 8(1):37–45
Kulkarni RB, Amin PD (2008) Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization. Drug Dev Ind Pharm 34(2):199–205
Kumar KS, Bhowmik D et al (2013) Recent trends in taste masking of bitter drugs. J Drug Deliv Res 1:1–11
Lindley M (2002) Composition comprising paracetamol and a bitterness masking component, US Patent App. 10/492,809
Maniruzzaman M, Boateng JS et al (2013) A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation. Drug Dev Ind Pharm 40(2):1–12
Özyazıcı M, Gökçe EH et al (2006) Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm 63(3):331–339
Reitz C, Strachan C et al (2008) Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties. Eur J Pharm Sci 35(4):335–343
Rowe RC, Sheskey PJ et al (2003) Handbook of pharmaceutical excipients. Pharmaceutical Press, London
Savolainen M, Khoo C et al (2002) Evaluation of controlled-release polar lipid microparticles. Int J Pharm 244(1):151–161
Shiino K, Iwao Y et al (2010) Optimization of a novel wax matrix system using amino alkyl methacrylate copolymer E and ethylcellulose to suppress the bitter taste of acetaminophen. Int J Pharm 395(1):71–77
Sohi H, Sultana Y et al (2004) Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm 30(5):429–448
Suzuki H, Onishi H et al (2003) Development of oral acetaminophen chewable tablets with inhibited bitter taste. Int J Pharm 251(1):123–132
Suzuki H, Onishi H et al (2004) Acetaminophen-containing chewable tablets with suppressed bitterness and improved oral feeling. Int J Pharm 278(1):51–61
Tripathi A, Parmar D et al (2011) Taste masking: a novel approach for bitter and obnoxious drugs. JPSBR 1(3):36–142
Venkatesan P, Manavalan R et al (2009) Microencapsulation: a vital technique in novel drug delivery system. J Pharm Sci Res 1(4):26–35
Wu Z, Patel A et al (2010) Development of acetaminophen proline prodrug. Bioorg Med Chem Lett 20(13):3851–3854
Yoshida T, Tasaki H et al (2009) Salting-out taste-masking system generates lag time with subsequent immediate release. Int J Pharm 365(1):81–88
Acknowledgments
This article does not contain any studies with animal subjects performed by any of the authors. All authors (W.M. El-Refaie, M.A. El-Massik, O.Y. Abdallah, and N.M. Khalafallah) declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El-Refaie, W.M., El-Massik, M.A., Abdallah, O.Y. et al. Formulation and evaluation of taste-masked paracetamol-lipid sachets and chewable tablets. Journal of Pharmaceutical Investigation 44, 431–442 (2014). https://doi.org/10.1007/s40005-014-0137-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-014-0137-0